Sarah L. Planchard, MPA-C

Sarah Planchard practices at Lucile Packard Children's Hospital Stanford in Palo Alto, California, part of Stanford University.

Sarah Planchard's NPI, 1942522495, was assigned on February 25, 2010. Sarah Planchard holds California license PA20841.

Sarah Planchard's primary practice is Lucile Packard Children's Hospital Stanford, at 725 Welch Road, Palo Alto, CA 94304 in Santa Clara County. The practice phone is (650) 497-8000.

Sarah Planchard's primary practice is Lucile Packard Children's Hospital Stanford in Palo Alto, California, part of Stanford University. The medical group on file is Vituity. Dmand AI also links Sarah Planchard to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sarah Planchard practices. Vendor and product names are available with a free account.

Medical is Sarah Planchard's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Sarah Planchard is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Sarah Planchard is licensed in California.

Dmand AI lists bursitis, fibromyalgia and chronic pain, hereditary polyneuropathy, joint pain, lower back pain, neck pain and spine problems, thoracic spine disorders and tobacco use among the conditions Sarah Planchard treats.

CMS data shows 122 Medicare services from Sarah Planchard across 3 procedure codes in 2024, all of them office visits, for 63 Medicare patients. Medicare paid $8,249 for them. Every service was in an office.

CMS counts 63 Medicare patients who saw Sarah Planchard in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have arthritis, and 75% have high blood pressure. 41% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Sarah Planchard's median patient age at 40, with 70% women.

In 2024, Sarah Planchard wrote 118 Medicare Part D claims for 19 patients. 97% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $291 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Sarah Planchard for performance year 2024, reported as part of a group.

CMS Open Payments shows 4 general payments to Sarah Planchard from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $58.